Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

264W 94

Known as: 264W94 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Thiazepines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
[The inhibitors of the apical sodium-dependent bile acid transporter (ASBT) as promising drugs].
Inhibition of the apical sodium-dependent bile acid transporter (ASBT, also known as IBAT - ileal bile acid transporter, SLC10A2… 
Highly Cited
2013
Highly Cited
2013
Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetes.
The apical sodium-dependent bile acid transporter (ASBT) transports bile salts from the lumen of the gastrointestinal (GI) tract… 
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Highly Cited
2012
Highly Cited
2012
Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes.
Bile acids are recognized as metabolic modulators. The present study was aimed at evaluating the effects of a potent Asbt… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2002
Highly Cited
2002
Ileal bile acid transporter inhibition, CYP7A1 induction, and antilipemic action of 264W94 DOI 10.1194/jlr.M200121-JLR200
264W94 was designed to inhibit the ileal bile acid transporter (IBAT). Evaluated in vitro, 264W94 dose-dependently inhibited… 
Highly Cited
1999
Highly Cited
1999
Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats.
The relationship between biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats was examined. The biliary… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE